?????????????.?????????????????????????????????????? 102 Conversely, several groups are advocating for the incorporation of novel markers, such as a complicated karyotype55 or epigenetic subsets, 27,28 into clinical apply. Each one of these novel prognostic and/or predictive versions will have to